News

Blog y noticias

Blog-amsterdam-ecvo-3-1200x675.png
07/Oct/2024

Glaucoma in animals is a chronic eye disease that affects both dogs and cats, among other species. It is usually characterized by an increase in intraocular pressure (IOP), which damages the optic nerve and retina, leading to progressive loss of vision and even blindness. As intraocular fluid, known as aqueous humor, accumulates due to a failure of its natural drainage, the pressure inside the eye increases, causing irreversible damage to the internal ocular structures.

The importance of the optic nerve and aqueous humor

The optic nerve is essential in the visual process, since it is responsible for transmitting the images captured by the retina to the brain, where they are processed to generate vision. This nerve is very sensitive to changes in pressure inside the eye. The aqueous humor, on the other hand, is a liquid that flows continuously inside the eye, providing nutrients to the internal ocular structures and eliminating waste. Under normal conditions, this fluid is drained through a specialized system in the iridocorneal angle, but in cases of glaucoma, this outflow is blocked or reduced, causing an accumulation of fluid that raises eye pressure.

There are two main types of glaucoma: primary glaucoma and secondary glaucoma. Primary glaucoma is related to genetic and anatomical causes, being more frequent in predisposed breeds of dogs, such as Cocker Spaniel or Maltese Bichon. Secondary glaucoma, on the other hand, arises as a consequence of other ocular diseases or trauma, such as chronic uveitis, lens dislocation or cataracts. The latter type is more common in cats.

Symptoms of glaucoma in animals

Glaucoma is a difficult disease to detect in its early stages, as animals usually adapt to the gradual loss of vision without showing obvious symptoms. However, as the disease progresses, clinical signs become more evident. Symptoms of glaucoma include:

  • Red eyes
  • Severe eye pain, causing the animal to rub its eyes or avoid light.
  • Dilated pupils that do not respond adequately to light
  • Blurred vision
  • Nausea, vomiting, irritability and behavioral changes due to pain
  • Cloudy appearance or bluish halo in the affected eye
  • Sensitivity to light (photophobia)
  • Disorientation or difficulty moving around in familiar spaces

In more advanced stages, animals may exhibit aggressive behavior or irritability due to severe pain. It is important to remember that animals can adapt to vision loss without noticing it in early stages, so regular veterinary checkups are crucial to detect and treat this disease early.

Diagnosis of glaucoma

Diagnosis of glaucoma requires a thorough ophthalmologic evaluation. The most common tests include tonometry, which measures IOP and determines whether it is within normal limits, and ophthalmoscopy, to assess the condition of the optic nerve and retina. In some cases, gonioscopy may be performed to observe the iridocorneal angle, where the aqueous humor drains, and to determine if there is an obstruction in the flow of this fluid.

Early detection is essential to prevent irreversible damage to the optic nerve and loss of vision. Unfortunately, in many pets glaucoma presents acutely, with obvious symptoms, making intervention urgent.

Treatment of glaucoma in animals

Treatment of glaucoma in animals is aimed at reducing IOP and preventing further vision loss. There are two main approaches: medical treatment and surgical treatment.

  1. Medical treatment: In less severe cases, glaucoma can be managed with medications that reduce the production of aqueous humor or improve its drainage. These medications are usually eye drops, although systemic treatments are also available.
  2. Surgical treatment: When medical treatment is not sufficient, surgery is used. There are two main options:
    • Laser: Used to reduce the production of aqueous humor in the affected eye.
    • Drainage implants: Valves or tubes are placed to allow the aqueous humor to drain out of the eye, reducing internal pressure.

Both treatments are aimed at preventing the progression of glaucoma and preserving vision, although in advanced cases blindness may be inevitable.

Nutraceuticals in the management of glaucoma

Nutraceuticals play a complementary role in the management of glaucoma, helping to protect the optic nerve and improve ocular microcirculation.  Glauco+ from Dr+Vet by AndersenPets is an example of a supplement specially formulated for animals with glaucoma. It contains ingredients such as:

  • Ginkgo biloba, which improves ocular circulation and helps protect the optic nerve from ischemic damage.
  • Vaccinium myrtillus (bilberry), rich in antioxidants that neutralize free radicals and improve ocular blood flow.
  • Citicoline, a neuroprotectant that supports visual function and the central nervous system by protecting retinal ganglion cells from oxidative stress.

The use of these nutraceuticals can help slow the progression of glaucoma and improve the quality of life of affected pets, although they should always be combined with appropriate medical and surgical treatment.

Glaucoma prevention

Since glaucoma can be asymptomatic in its early stages, prevention is key. Genetically predisposed breeds, such as Cocker Spaniel, French Bulldog and Maltese Bichon, should undergo regular ophthalmologic checkups to detect any early signs of the disease. In some cases, veterinarians may prescribe preventive eye drops to lower IOP in pets with a family history of glaucoma.

In general, glaucoma is a disease that requires multidisciplinary management. The combination of medication, surgery and nutraceuticals may offer a better prognosis and preserve vision longer. It is essential that veterinarians watch for clinical signs and educate guardians on the importance of ophthalmologic examinations to detect glaucoma early.


2.png
23/Oct/2023

From Dr+Vet we are pleased to announce our improvement in the formula of our classic Glauco, the veterinary nutraceutical focused to provide nutrients to the retina and offer neuroprotection to the optic nerve to prevent its degeneration, very relevant in cases of Glaucoma.

Glaucoma is a progressive optic retinopathy and one of the major causes of blindness in humans, it is characterized by optic nerve degeneration, loss of retinal ganglion cells (RGC) and cause restructuring of nerve tissues, causing visual loss.
The factors causing this condition are diverse and complex. Increased intraocular pressure (IOP) has been identified as one of the main drivers of glaucoma and is also the mainstay in the treatment of this disease, focusing on topical and systemic IOP-lowering treatments. Although even though IOP can be effectively controlled, there are patients whose disease still progresses, causing irreversible vision loss.
It is for this reason that Dr+Vet created Glauco+, a nutritional supplement with several natural components that help to generate positive effects on the retina and offer protection against the progression of this disease. Through the incorporation of Citicoline, a molecule that has demonstrated its potential in studies on neurodegenerative diseases, we are opening a door towards a more complete approach to the management of glaucoma in our pets.

Discovering the Potential of Citicoline
In the constant quest to improve treatments for glaucoma in pets, ophthalmic specialists have played a key role in the evolution of therapeutic options. It is for this reason that the incorporation of citicoline in the Glauco+ formula has been a long-awaited and much-requested addition by these eye health experts. Citicoline has garnered considerable attention in the field of neurodegenerative diseases. Research in human medicine has shown its potential benefits in conditions such as senile dementia, Parkinson’s disease and glaucoma. Its introduction in Glauco+ aims to take advantage of these potential benefits for pets.

Citicoline, also known as cytidine-5′-diphosphocholine, is essential for synthesizing membrane phospholipids, including phosphatidylcholine. This compound participates in several metabolic pathways, playing roles in phospholipid homeostasis, mitochondrial dynamics and neurotransmission, especially in the complex mechanism of visual transmission.
When administered orally, Citicoline is efficiently absorbed in the intestines, being transformed into choline and cytidine in the digestive tract and liver. These compounds cross the blood-brain barrier, becoming precursors of vital metabolites. These include phospholipids, nucleic acids, proteins, sphingomyelin, cardiolipin and acetylcholine, a major neurotransmitter in the cholinergic system that modulates visual processes.
In human clinical studies, the ability of citicoline to counteract glutamate-mediated excitotoxicity and oxidative stress, factors that play a crucial role in glaucoma-associated neuronal damage, has been observed. In addition, its influence on the regulation of neurotransmitters such as dopamine and acetylcholine has been linked to improvements in visual function, which translates into a positive impact on quality of life.

Not only has citicoline been shown to protect damaged retinal ganglion cells, but it also acts to improve mitochondrial function and cell membrane integrity. These effects are particularly relevant in the context of glaucoma, where mitochondrial aging processes and neuronal axon damage are characteristic features of the disease.

The classic Glauco components are still present
The Glauco+ approach is based on the combination of natural components, each with its own unique properties and benefits. These components have been selected to address multiple factors, providing a comprehensive solution.
Ginkgo biloba: Native to Asia, this medicinal plant has been appreciated for its properties in traditional medicine for centuries. The extracts of its leaves are rich in flavonoids and terpenoids, which have shown beneficial effects on blood circulation, reduction of blood viscosity, increase in retinal blood flow and neuroprotection.
Anthocyanins (Vaccinium myrtillus, wild blueberry): These natural pigments, present in fruits and vegetables, help improve blood circulation and show antioxidant action. They have an affinity for vascular tissues and have been recognized as beneficial for eye health. Anthocyanins have been shown to contribute to the normalization of retinal blood flow.
Vitamin B3 (Niacinamide or Nicotinamide): This essential vitamin acts as a precursor to the coenzyme nicotinamide adenine dinucleotide (NAD+), vital for mitochondrial function and energy production in retinal ganglion cells. The decrease in NAD+ levels with age and in neurodegenerative diseases, such as glaucoma, has been documented. Supplementation with vitamin B3 has been shown to be a powerful neuroprotectant, preventing neuronal damage and mitochondrial dysfunction.
Vitamin B9 (folic acid) and Vitamin B12 – These B vitamins play a key role in regulating levels of homocysteine, an amino acid linked to retinal damage. The relationship between elevated homocysteine levels and eye damage has been highlighted in several studies. Taking vitamins B12 and B9, in particular, has been associated with reducing homocysteine levels, which could be beneficial in preventing this form of damage.

New tablet format divisible into 4 parts
With the new format divisible into 4 parts, we offer the possibility of adjusting the dose of Glauco+ according to the individual needs of each pet. This new format makes dosing more personalized and precise than with the old format. Offering the possibility of dosing from 2.5kg onwards.
How to get Glauco+?
To purchase Glauco+, you can obtain it exclusively through veterinary distributors in specialized clinics. This measure guarantees that you receive the product under the guidance and supervision of animal health professionals.

In summary
The inclusion of citicoline in Glauco+ represents a step forward in the search for more complete dietary supplements for the eye health of pets. The support and recommendation of ophthalmologists specialized in ocular health are the basis for the development of new and improved products focused especially on veterinary medicine.

From Dr+Vet we want to remember that Glauco+ will be available from November and that at AVEPA-SEVC we will be presenting the product.


Copyright by Boothmen Pharma 2023. All rights reserved.